Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImExHS Limited ( (AU:IME) ) has provided an announcement.
IMEXHS Limited held its 2025 Annual General Meeting, where shareholders voted on several resolutions, including the re-election of directors and the approval of options grants. The meeting also approved a 10% share placement capacity. These decisions are expected to impact the company’s governance and financial strategies, potentially influencing its market positioning and stakeholder interests.
The most recent analyst rating on (AU:IME) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
IMEXHS Limited is an innovative provider of medical imaging software and radiology services, operating in 18 countries. Founded in 2012, the company offers cloud-based, vendor-neutral solutions such as Picture Archiving and Communications System (PACS), Radiology Information System (RIS), Cardiology Information System (CIS), and Anatomical Pathology Laboratory Information System (APLIS). These solutions are designed to enhance productivity, reduce costs, and improve patient outcomes.
Average Trading Volume: 23,933
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$17.52M
See more insights into IME stock on TipRanks’ Stock Analysis page.